Saralasin and sarile are AT2 receptor agonists

ACS Medicinal Chemistry Letters

Volumn 5, Issue 10, 2014, Pages 1129-1132

  Guimond, Marie Odile ^a   Hallberg, Mathias ^b   Gallo Payet, Nicole ^a   Wallinder, Charlotta ^c  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b UPPSALA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

AT2 receptor agonist; C21 M024; peptide ligands; Saralasin; sarile

Indexed keywords

ANGIOTENSIN II RECEPTOR AGONIST; ANGIOTENSIN RECEPTOR; HORMONE RECEPTOR AFFECTING AGENT; SARALASIN; SARILE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CONTROLLED STUDY; DRUG BINDING SITE; IN VITRO STUDY; NERVE FIBER GROWTH; NONHUMAN; PHASE CONTRAST MICROSCOPY;

EID: 84907932247     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml500278g     Document Type: Article

References (32)

1. Khosla, M. C.; Smeby, R. R.; Bumpus, F. M. Structure-Activity Relation in Angiotensin II Analogs. In Handbook of Experimental Pharmacology; Page, I. H., Bumpus, F. M., Eds.; Springer-Verlag: Berlin, Germany, 1974; Vol. 37, pp 126-61.
2. Pals, D. T.; Masucci, F. D.; Denning, G. S.; Sipos, F.; Fessler, D. C. Role of the pressor action of angiotensin II in experimental hypertension Circ. Res. 1971, 29, 673-681
3. Hata, T.; Ogihara, T.; Mikami, H.; Nakamura, M.; Maruyama, A.; Mandai, T.; Kumahara, Y. Comparison of the biological effects of two angiotensin II analogues in hypertensive patients with sodium depletion Life Sci. 1978, 22, 1955-1962
4. Moore, G. J. Angiotensin and Bradykinin Receptors. In Comprehensive Medicinal Chemistry; Emmett, J. C., Ed.; Pergamon Press: New York, 1990; Vol. 3, pp 961-980.
5. Hodges, J. C.; Hamby, J. M.; Blankley, C. J. Angiotensin II receptor binding inhibitors Drugs Future 1992, 17, 575-593
6. Samanen, J.; Regoli, D. Structure-Activity Relationships of Peptide Angiotensin II Receptor Agonists and Antagonists. In Angiotensin II Receptors; Ruffolo, R. R., Jr., Ed.; CRC Press, Inc.: Boca Raton, FL, 1994; Vol. 2, pp 11-97.
7. Ondetti, M. A.; Rubin, B.; Cushman, D. W. Design of specific inhibitors of angiotensin-converting enzyme: New class of orally active antihypertensive agents Science 1977, 196, 441-444
8. Staessen, J. A.; Li, Y.; Richart, T. Oral renin inhibitors Lancet 2006, 368, 1449-1456
9. Regoli, D.; Rioux, F.; Park, W. K.; Choi, C. Role of the N-terminal amino acid for the biological activities of angiotensin and inhibitory analogues Can. J. Physiol. Pharmacol. 1974, 52, 39-49
10. Hsieh, K.-H.; LaHann, T. R.; Speth, R. C. Topographic probes of angiotensin and receptor: Potent angiotensin II agonist containing diphenylalanine and long-acting antagonists containing biphenylalanine and 2-indan amino acid in position 8 J. Med. Chem. 1989, 32, 898-903
11. Aumelas, A.; Sakarellos, C.; Lintner, K.; Fermandjian, S.; Khosla, M. C.; Smeby, R. R.; Bumpus, M. F. Studies on angiotensin II and analogs: impact of substitution in position 8 on conformation and activity Proc. Natl. Acad. Sci. U.S.A. 1985, 82, 1881-1885
12. Criscione, L.; Thomann, H.; Whitebread, S.; de Gasparo, M.; Bühlmayer, P.; Herold, P.; Ostermayer, F.; Kamber, B. Binding characteristics and vascular effects of various angiotensin II antagonists J. Cardiovasc. Pharmacol. 1990, 16 (Suppl. 4) S56-S59
13. 2 receptor modulates T-type calcium current in non-differentiated NG108-15 cells FEBS Lett. 1992, 309, 161-164
14. Guimond, M. O.; Roberge, C.; Gallo-Payet, N. Fyn is involved in angiotensin II type 2 receptor-induced neurite outgrowth, but not in p42/p44mapk in NG108-15 cells Mol. Cell. Neurosci. 2010, 45, 201-212
15. 2 receptor in PC12W cells Regul. Pept. 1993, 44, 207-213
16. 2 receptor of angiotensin II and neuronal differentiation: From observations to mechanisms J. Mol. Endocrinol. 2003, 31, 359-372
17. 1 receptors J. Biol. Chem. 1996, 271, 22729-22735
18. 2 subtype J. Med. Chem. 1991, 34, 3248-3260
19. 6 angiotensin II Biochem. Biophys. Res. Commun. 1990, 169, 997-1006
20. 2 receptor affinity Bioorg. Med. Chem. 2006, 14, 5963-5972
21. 2 receptor ligands encompassing a g-turn mimetic replacing the amino acid residues 4-5 of angiotensin II act as agonists J. Med. Chem. 2005, 48, 4009-4024
22. Rice, A. S. C.; Dworkin, R. H.; McCarthy, T. D.; Anand, P.; Bountra, C.; McCloud, P. I.; Hill, J.; Cutter, G.; Kitson, G.; Desem, N.; Raff, M. EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial Lancet 2014, 383, 1637-1647
23. Danser, A. H. J.; Anand, P. The angiotensin II type 2 receptor for pain control Cell 2014, 157, 1504-1506
24. 2 receptor agonist J. Med. Chem. 2004, 47, 5995-6008
25. Murugaiah, A. M.; Wallinder, C.; Mahalingam, A. K.; Wu, X.; Wan, Y.; Plouffe, B.; Botros, M.; Karlen, A.; Hallberg, M.; Gallo-Payet, N.; Alterman, M. Selective angiotensin II AT(2) receptor agonists devoid of the imidazole ring system Bioorg. Med. Chem. 2007, 15, 7166-83
26. 2 receptor agonists: benzamide structure-activity relationships Bioorg. Med. Chem. 2008, 16, 6841-6849
27. 2 receptor agonist to structurally related antagonists J. Med. Chem. 2012, 55, 2265-2278
28. 2) receptor. Effects on neurite outgrowth in NG108-15 cells Eur. J. Pharmacol. 2013, 699, 160-171
29. Sauliere, A.; Bellot, M.; Paris, H.; Denis, C.; Finana, F.; Hansen, J. T.; Altie, M. F.; Seguelas, M. H.; Pathak, A.; Hansen, J. L.; Senard, J. M.; Gales, C. Deciphering biased-agonism complexity reveals a new active AT1 receptor entity Nat. Chem. Biol. 2012, 8, 622-30
30. Godin, C. M.; Fergusson, S. S. G. Biased agonism of the angiotensin II type 1 receptor Mini-Rev. Med. Chem. 2012, 12, 812-816
31. Steckelings, U. M.; Rompe, F.; Kaschina, E.; Namsolleck, P.; Grzesiak, A.; Funke-Kaiser, H.; Bader, M.; Unger, T. The past, present and future of angiotensin II type 2 receptor stimulation J. Renin-Angiotensin-Aldosterone Syst. 2010, 11, 67-73
32. Gendron, L.; Cote, F.; Payet, M. D.; Gallo-Payet, N. Nitric oxide and cyclic GMP are involved in angiotensin II AT(2) receptor effects on neurite outgrowth in NG108-15 cells Neuroendocrinology 2002, 75, 70-81